256 Views
Category: Pediatric Bacterial Studies (natural history and therapuetic)
Poster Session: Pediatric Bacterial Studies (natural history and therapuetic)
Kristina G. Hulten
Associate Professor
Baylor College of Medicine
Houston, Texas
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
William J. Barson
Professor
Ohio State University College of Medicine and Public Health and Nationwide Children's Hospital
Columbus, Ohio
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
P. Ling Lin
Associate Professor
University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
John S. Bradley
Distinguished Professor of Pediatrics
University of California, San Diego
San Diego, CA
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Timothy R. Peters
Associate Professor
Wake Forest School of Medicine and Wake Forest Baptist Health
Winston Salem, NC
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tina Q. Tan
Professor
Feinberg School of Medicine, Northwestern University
Chicago, Illinois
Disclosure: Pfizer (Grant/Research Support, Other Financial or Material Support, Chair, DMSB for PCV20 vaccine)
Jose R. Romero
Professor
University of Arkansas for Medical Sciences and Arkansas Children's Hospital
Little Rock, Arkansas
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Pia S. Pannaraj
Professor
University of California San Diego
La Jolla, CA
Disclosure: AstraZeneca (Grant/Research Support)Pfizer (Grant/Research Support)Sanofi Pasteur (Advisor or Review Panel member)
Sheldon L. Kaplan
Professor
Baylor College of Medicine
Houston, Texas
Disclosure: Allergan (Research Grant or Support)Pfizer (Grant/Research Support)
Vaccine Effectiveness | 0-1 Doses of PCV13 | 3 or More Doses of PCV13 |
PCV13 serotype | 39 | 59 |
Non-PCV13 serotypes | 41 | 456 |